Trials / Conditions / Neoplasm Metastases

Neoplasm Metastases

19 registered clinical trials studyying Neoplasm Metastases — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas NCT05419518	Rutgers, The State University of New Jersey	Phase 2
Recruiting	HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388	M.D. Anderson Cancer Center	Phase 1
Unknown	Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions NCT02789371	Bin Cheng	N/A
Completed	Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) NCT02808416	Guangdong 999 Brain Hospital	Phase 1
Completed	Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A) NCT02953756	Elisabeth-TweeSteden Ziekenhuis	—
Unknown	Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupyi NCT02327065	Huazhong University of Science and Technology	N/A
Completed	Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain NCT02382653	Tanta University	N/A
Recruiting	Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE) NCT02246634	Imperial College London	N/A
Terminated	Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases NCT01970644	CancerCare Manitoba	—
Terminated	Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-13 NCT02565433	Centre Oscar Lambret	N/A
Terminated	Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads NCT01336985	National Institutes of Health Clinical Center (CC)	Phase 1
Completed	A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients Wit NCT01267084	Janssen Research & Development, LLC	Phase 1 / Phase 2
Completed	A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Ad NCT01273480	Janssen Research & Development, LLC	Phase 1
Completed	A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction NCT01273493	Janssen Research & Development, LLC	Phase 1
Completed	Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors NCT01122199	Shadia Jalal	Phase 1
Completed	Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carc NCT00556049	Massachusetts General Hospital	Phase 2
Completed	Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection NCT00668382	University of Massachusetts, Worcester	Phase 1
Completed	Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T. NCT00184353	Norwegian University of Science and Technology	—
Completed	Stereotactic Radiotherapy (SRT) Liver (COLD 1) NCT00152906	University Health Network, Toronto	Phase 1 / Phase 2